TECVAYLI sol inj 153 mg/1.7ml flac 1.7 ml
7680687470025
CH-68747
L01FX24
07.16.1.
Reimbursement limitations:
TECVAYLI
Après garantie de prise en charge des coûts par l’assureur-maladie après consultation préalable du médecin-conseil.
…
1 / 3
google
Details
- Product number
- 6874702
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- teclistamabum 153 mg, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 20, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml corresp. natrium 0.43 mg.
Articles (1)
Tecvayli 153 mg/1.7 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
153.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.43 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 4285.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2023
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 68747
- Drug name
- Tecvayli, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01FX24
- Authorization status
- B
- Dispensation category
- A
- First authorization
- 22/12/2022
- Authorization expiration date
- 30/06/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TECVAYLI sol inj 153 mg/1.7ml flac 1.7 ml
- Description (DE)
- TECVAYLI Inj Lös 153 mg/1.7ml Durchstf 1.7 ml
- Market launch
- 22/12/2022
- Narcotic (BTM)
- No